SKIN SKINHEALTH SYSTEMS INC revenue, earnings and financials

For the quarter ended June 30, 2026, SKINHEALTH SYSTEMS INC reported revenue of $72.1M (down 7.8% from a year earlier), net income of −$2.67M and diluted EPS of −$0.02; over the last four quarters revenue was $290M and net income −$28.4M; for the fiscal year ended December 2025 revenue was $301M, down 10.0% on the year before.

SKIN annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $301M, gross profit $196M, operating income −$20.8M, net income −$9.50M (margin -3.2%), EPS −$0.16
• Fiscal year ended Dec 2024: revenue $334M, gross profit $182M, operating income −$67.8M, net income −$29.1M (margin -8.7%), EPS −$0.36
• Fiscal year ended Dec 2023: revenue $398M, gross profit $155M, operating income −$131M, net income −$100M (margin -25.2%), EPS −$0.76
• Fiscal year ended Dec 2022: revenue $366M, gross profit $249M, operating income −$25.8M, net income $44.2M (margin 12.1%), EPS −$0.23
• Fiscal year ended Dec 2021: revenue $260M, gross profit $179M, operating income −$39.9M, net income $379M (margin 145.6%), EPS −$3.71

SKIN quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $72.1M (down 7.8% year over year), net income −$2.67M, EPS −$0.02
• Quarter ended Mar 31, 2026: revenue $64.9M (down 6.7% year over year), net income −$6.63M, EPS −$0.05
• Quarter ended Dec 31, 2025 (from the annual report): revenue $82.4M (down 1.3% year over year), net income −$8.09M, EPS −$0.02
• Quarter ended Sep 30, 2025: revenue $70.7M (down 10.3% year over year), net income −$11.0M, EPS −$0.09
• Quarter ended Jun 30, 2025: revenue $78.2M (down 13.7% year over year), net income $19.7M, EPS $0.03
• Quarter ended Mar 31, 2025: revenue $69.6M (down 14.5% year over year), net income −$10.1M, EPS −$0.08
• Quarter ended Dec 31, 2024 (from the annual report): revenue $83.5M (down 13.8% year over year), net income −$10.3M, EPS −$0.01
• Quarter ended Sep 30, 2024: revenue $78.8M (down 19.1% year over year), net income −$18.3M, EPS −$0.15
• Quarter ended Jun 30, 2024: revenue $90.6M (down 22.9% year over year), net income $202K, EPS −$0.10
• Quarter ended Mar 31, 2024: revenue $81.4M (down 5.7% year over year), net income −$679K, EPS −$0.10
• Quarter ended Dec 31, 2023 (from the annual report): revenue $96.8M (down 1.3% year over year), net income −$9.39M, EPS −$0.08
• Quarter ended Sep 30, 2023: revenue $97.4M (up 9.7% year over year), net income −$73.8M, EPS −$0.56
• Quarter ended Jun 30, 2023: revenue $117M (up 13.5% year over year), net income $3.36M, EPS $0.03
• Quarter ended Mar 31, 2023: revenue $86.3M (up 14.4% year over year), net income −$20.3M, EPS −$0.15
• Quarter ended Dec 31, 2022 (from the annual report): revenue $98.1M (up 26.0% year over year), net income $6.51M, EPS −$0.01
• Quarter ended Sep 30, 2022: revenue $88.8M (up 30.3% year over year), net income −$81.0K, EPS −$0.03
• Quarter ended Jun 30, 2022: revenue $104M (up 55.7% year over year), net income $6.32M, EPS −$0.06
• Quarter ended Mar 31, 2022: revenue $75.4M (up 58.6% year over year), net income $31.5M, EPS −$0.13
• Quarter ended Dec 31, 2021 (from the annual report): revenue $77.9M, net income $736M, EPS −$0.47
• Quarter ended Sep 30, 2021: revenue $68.1M, net income −$215M, EPS −$1.63

SKIN cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $37.5M, share buybacks $0
• Fiscal year ended Dec 2024: operating cash flow $16.1M, share buybacks $0
• Fiscal year ended Dec 2023: operating cash flow $21.8M, share buybacks $30.2M
• Fiscal year ended Dec 2022: operating cash flow −$107M, share buybacks $160M
• Fiscal year ended Dec 2021: operating cash flow −$28.4M, share buybacks $0

SKIN balance sheet

• Jun 30, 2026: cash n/a, total assets $487M, total liabilities $431M, shareholders' equity $55.6M
• Mar 31, 2026: cash n/a, total assets $473M, total liabilities $418M, shareholders' equity $55.2M
• Dec 31, 2025: cash n/a, total assets $500M, total liabilities $439M, shareholders' equity $61.1M
• Sep 30, 2025: cash n/a, total assets $504M, total liabilities $438M, shareholders' equity $65.7M
• Jun 30, 2025: cash n/a, total assets $508M, total liabilities $434M, shareholders' equity $74.0M
• Mar 31, 2025: cash n/a, total assets $674M, total liabilities $628M, shareholders' equity $46.1M
• Dec 31, 2024: cash n/a, total assets $686M, total liabilities $634M, shareholders' equity $51.8M
• Sep 30, 2024: cash n/a, total assets $700M, total liabilities $640M, shareholders' equity $59.7M

What is SKIN's revenue?

SKINHEALTH SYSTEMS INC reported $290M of revenue over its last four quarters, through June 30, 2026.

Is SKIN profitable?

No. SKINHEALTH SYSTEMS INC lost $28.4M over the last four quarters.

What is SKIN's EPS?

Diluted earnings per share over the last four quarters were −$0.18; −$0.02 in the latest quarter.

SKIN ownership and insider trades · All stocks